Walthausen & Co’s NeoGenomics NEO Stock Holding History

Walthausen & Co’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-77,810	Closed	-$981K	–	143
2018 Q4	$981K	Sell	77,810 -14,240	-15%	-$212K	0.14%	134
2018 Q3	$1.41M	Buy	+92,050	New	+$1.27M	0.14%	115

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Walthausen & Co's NEO Position: Q1 2019 in Review

Walthausen & Co sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 77,810 shares — an estimated $981K sold.

Walthausen & Co first reported a position in NEO in Q3 2018 and held it in 2 quarters. The position peaked at $1.41M in Q3 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

Walthausen & Co reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
Walthausen & Co sold 77,810 NeoGenomics shares in Q1 2019, an estimated $981K.
Walthausen & Co first reported a position in NeoGenomics in Q3 2018 and held it in 2 quarters.
Walthausen & Co's NeoGenomics position peaked at $1.41M in Q3 2018.
235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on Walthausen & Co's 13F filing for Q1 2019, filed 10 May 2019.